Newsmeme!
Discover News you didn't know existed
700,000 women have their tubes tied each year. There are many more women who decide their family is complete, but stick with traditional, temporary methods of contraception. But Carolyn Clifford...
The Sonoma Valley Community Health Center has been rapidly outgrowing its West Napa Street location for years.
A new Northwestern University-led study of human colon, pancreatic and lung cells is the first to report that cancer cells and their non-cancerous cell neighbors, although quite different under the microscope, share very similar structural abnormalities on the nanoscale level.
Conception success and pregnancy can depend on who your healthcare provider is and how aggressive he or she is on your behalf. How can you pick the right one for you?
The final analysis of the largest efficacy trial of a cervical cancer vaccine is published today in The Lancet. The study, involving 18,644 women, confirmed GlaxoSmithKline's Cervarix(R) is highly effective at protecting against the two most common cervical cancer-causing human papillomavirus (HPV) types, 16 and 18.
Maryville College officials are evaluating whether its campus and the Blount County community can host a nationally-recognized program committed to improving the lives of low-income, middle-age Appalachian women.
Comedy Central will finally see some girl-on-girl roasting: Kathy Griffin will serve as Roast Master at Comedy Central's Roast of Joan Rivers, the network announced.
A new Northwestern University-led study of human colon, pancreatic and lung cells is the first to report that cancer cells and their non-cancerous cell neighbors, although quite different under the microscope, share very similar structural abnormalities on the nanoscale level.The findings, obtained using an optical technique that can detect features as small as 20 nanometers, validate the "field ...
Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease. Results from a study... Sponsored Topics: Cervical cancer - Human papillomavirus - Cervarix - HPV vaccine - Cancer
By The Associated Press NEW YORK (AP) -- Drugmaker GlaxoSmithKline PLC said Tuesday a study shows its human papillomavirus vaccine Cervarix was effective against the types of HPV that are most likely to cause cervical cancer, but also fought other strains of the disease.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |